Unknown

Dataset Information

0

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.


ABSTRACT: BACKGROUND:A previous RTS,S/AS01B vaccine challenge trial demonstrated that a 3-dose (0-1-7-month) regimen with a fractional third dose can produce high vaccine efficacy (VE) in adults challenged 3 weeks after vaccination. This study explored the VE of different delayed fractional dose regimens of adult and pediatric RTS,S/AS01 formulations. METHODS:A total of 130 participants were randomized into 5 groups. Four groups received 3 doses of RTS,S/AS01B or RTS,S/AS01E on a 0-1-7-month schedule, with the final 1 or 2 doses being fractional (one-fifth dose volume). One group received 1 full (month 0) and 1 fractional (month 7) dose of RTS,S/AS01E. Immunized and unvaccinated control participants underwent Plasmodium falciparum-infected mosquito challenge (controlled human malaria infection) 3 months after immunization, a timing chosen to potentially discriminate VEs between groups. RESULTS:The VE of 3-dose formulations ranged from 55% (95% confidence interval, 27%-72%) to 76% (48%-89%). Groups administered equivalent formulations of RTS,S/AS01E and RTS,S/AS01B demonstrated comparable VE. The 2-dose group demonstrated lower VE (29% [95% confidence interval, 6%-46%]). All regimens were well tolerated and immunogenic, with trends toward higher anti-circumsporozoite antibody titers in participants protected against infection. CONCLUSIONS:RTS,S/AS01E can provide VE comparable to an equivalent RTS,S/AS01B regimen in adults, suggesting a universal formulation may be considered. Results also suggest that the 2-dose regimen is inferior to the 3-dose regimens evaluated. CLINICAL TRIAL REGISTRATION:NCT03162614.

SUBMITTER: Moon JE 

PROVIDER: S-EPMC7552430 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.

Moon James E JE   Ockenhouse Christian C   Regules Jason A JA   Vekemans Johan J   Lee Cynthia C   Chuang Ilin I   Traskine Magali M   Jongert Erik E   Ivinson Karen K   Morelle Danielle D   Komisar Jack L JL   Lievens Marc M   Sedegah Martha M   Garver Lindsey S LS   Sikaffy April K AK   Waters Norman C NC   Ballou William Ripley WR   Ofori-Anyinam Opokua O  

The Journal of infectious diseases 20201001 10


<h4>Background</h4>A previous RTS,S/AS01B vaccine challenge trial demonstrated that a 3-dose (0-1-7-month) regimen with a fractional third dose can produce high vaccine efficacy (VE) in adults challenged 3 weeks after vaccination. This study explored the VE of different delayed fractional dose regimens of adult and pediatric RTS,S/AS01 formulations.<h4>Methods</h4>A total of 130 participants were randomized into 5 groups. Four groups received 3 doses of RTS,S/AS01B or RTS,S/AS01E on a 0-1-7-mont  ...[more]

Similar Datasets

| S-EPMC2714466 | biostudies-literature
| S-EPMC4769081 | biostudies-literature
| S-EPMC6177476 | biostudies-literature
| S-EPMC5156295 | biostudies-literature
| S-EPMC5554171 | biostudies-literature
| S-EPMC2750750 | biostudies-literature
| S-EPMC2655100 | biostudies-literature
| S-EPMC6520358 | biostudies-literature
2020-05-13 | GSE144826 | GEO
| S-EPMC6068239 | biostudies-literature